Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) HydrALAZINE Hydrochloride Tablets, USP, 25mg (hydralazine hydrochloride) tablets
Section 19A approved medicine
(Approval lapsed) HydrALAZINE Hydrochloride Tablets, USP, 25mg (hydralazine hydrochloride) tablets
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
ALPHAPRESS 25 hydralazine hydrochloride 25mg tablet bottle - ARTG 17575
ALPHAPRESS 50 hydralazine hydrochloride 50mg tablet bottle - ARTG 60380
ALPHAPRESS 50 hydralazine hydrochloride 50mg tablet bottle - ARTG 60380
Indication(s)
Treatment of drug resistant, moderate to severe, hypertension. This drug is not a first line antihypertensive drug and is better used in combination with other antihypertensives such as beta-blockers and diuretics.